Qu M, Gao B, Jiang Y, Li Y, Pei C, Xie L
Brain Imaging Behav. 2024; 18(3):475-484.
PMID: 38170304
PMC: 11222218.
DOI: 10.1007/s11682-023-00844-9.
Jones J, Dominguez B, Bunch J, Uribe C, Valenzuela Y, Jacobs J
Clin Park Relat Disord. 2021; 5:100104.
PMID: 34430845
PMC: 8368023.
DOI: 10.1016/j.prdoa.2021.100104.
Selvaraj S, Piramanayagam S
Genes Dis. 2019; 6(2):120-128.
PMID: 31193965
PMC: 6545447.
DOI: 10.1016/j.gendis.2019.01.004.
Grover S, Somani A, Sahni N, Mehta S, Choudhary S, Chakravarty R
Innov Clin Neurosci. 2018; 15(1-2):23-27.
PMID: 29497576
PMC: 5819717.
Zhong P, Vickstrom C, Liu X, Hu Y, Yu L, Yu H
Elife. 2017; 7.
PMID: 29256865
PMC: 5749952.
DOI: 10.7554/eLife.32420.
Nortriptyline inhibits aggregation and neurotoxicity of alpha-synuclein by enhancing reconfiguration of the monomeric form.
Collier T, Srivastava K, Justman C, Grammatopoulous T, Hutter-Paier B, Prokesch M
Neurobiol Dis. 2017; 106:191-204.
PMID: 28711409
PMC: 5793922.
DOI: 10.1016/j.nbd.2017.07.007.
Neuropsychiatric Burden in Huntington's Disease.
Paoli R, Botturi A, Ciammola A, Silani V, Prunas C, Lucchiari C
Brain Sci. 2017; 7(6).
PMID: 28621715
PMC: 5483640.
DOI: 10.3390/brainsci7060067.
Exploring Music-Based Rehabilitation for Parkinsonism through Embodied Cognitive Science.
Schiavio A, Altenmuller E
Front Neurol. 2015; 6:217.
PMID: 26539155
PMC: 4609849.
DOI: 10.3389/fneur.2015.00217.
Parkinson's Disease, Depression, and Quality-of-Life.
Menon B, Nayar R, Kumar S, Cherkil S, Venkatachalam A, Surendran K
Indian J Psychol Med. 2015; 37(2):144-8.
PMID: 25969597
PMC: 4418244.
DOI: 10.4103/0253-7176.155611.
A randomized clinical trial to evaluate the effects of rasagiline on depressive symptoms in non-demented Parkinson's disease patients.
Barone P, Santangelo G, Morgante L, Onofrj M, Meco G, Abbruzzese G
Eur J Neurol. 2015; 22(8):1184-91.
PMID: 25962410
PMC: 4676931.
DOI: 10.1111/ene.12724.
Neuropsychiatric co-morbidities in non-demented Parkinson's disease.
Rai N, Goyal V, Kumar N, Shukla G, Srivastava A, Singh S
Ann Indian Acad Neurol. 2015; 18(1):33-8.
PMID: 25745308
PMC: 4350211.
DOI: 10.4103/0972-2327.144287.
The Natural History of Depression in Parkinson's Disease within 30-Month Follow-Up.
Xu Y, Kuo S, Liang Z, Xu H, Feng W, Yu C
Parkinsons Dis. 2015; 2015:362892.
PMID: 25722914
PMC: 4333563.
DOI: 10.1155/2015/362892.
Psychiatric aspects of Parkinson's disease.
Grover S, Somaiya M, Kumar S, Avasthi A
J Neurosci Rural Pract. 2015; 6(1):65-76.
PMID: 25552854
PMC: 4244792.
DOI: 10.4103/0976-3147.143197.
Antidepressant activity of the adenosine A2A receptor antagonist, istradefylline (KW-6002) on learned helplessness in rats.
Yamada K, Kobayashi M, Shiozaki S, Ohta T, Mori A, Jenner P
Psychopharmacology (Berl). 2014; 231(14):2839-49.
PMID: 24488405
DOI: 10.1007/s00213-014-3454-0.
Association between fatigue and other motor and non-motor symptoms in Parkinson's disease patients.
Solla P, Cannas A, Mulas C, Perra S, Corona A, Bassareo P
J Neurol. 2013; 261(2):382-91.
PMID: 24375016
DOI: 10.1007/s00415-013-7207-5.
Non-motor parkinsonian pathology in aging A53T α-synuclein mice is associated with progressive synucleinopathy and altered enzymatic function.
Farrell K, Krishnamachari S, Villanueva E, Lou H, Alerte T, Peet E
J Neurochem. 2013; 128(4):536-46.
PMID: 24117685
PMC: 4283050.
DOI: 10.1111/jnc.12481.
Premotor biomarkers for Parkinson's disease - a promising direction of research.
Haas B, Stewart T, Zhang J
Transl Neurodegener. 2012; 1(1):11.
PMID: 23211054
PMC: 3514104.
DOI: 10.1186/2047-9158-1-11.
Inhibition of bupropion metabolism by selegiline: mechanism-based inactivation of human CYP2B6 and characterization of glutathione and peptide adducts.
Sridar C, Kenaan C, Hollenberg P
Drug Metab Dispos. 2012; 40(12):2256-66.
PMID: 22936314
PMC: 3500550.
DOI: 10.1124/dmd.112.046979.
Depression in Parkinson disease--epidemiology, mechanisms and management.
Aarsland D, Pahlhagen S, Ballard C, Ehrt U, Svenningsson P
Nat Rev Neurol. 2011; 8(1):35-47.
PMID: 22198405
DOI: 10.1038/nrneurol.2011.189.
Noradrenaline and Parkinson's disease.
Delaville C, De Deurwaerdere P, Benazzouz A
Front Syst Neurosci. 2011; 5:31.
PMID: 21647359
PMC: 3103977.
DOI: 10.3389/fnsys.2011.00031.